Holen Sie sich die Stockscreener-App
3.11
4.01%
-0.13
Vorhandelsmarkt:
3.11
Schlusskurs vom Vortag:
$3.24
Offen:
$3.23
24-Stunden-Volumen:
1.45M
Relative Volume:
1.76
Marktkapitalisierung:
$257.65M
Einnahmen:
$70.14M
Nettoeinkommen (Verlust:
$-76.24M
KGV:
-2.8018
EPS:
-1.11
Netto-Cashflow:
$-57.06M
1W Leistung:
+10.28%
1M Leistung:
+23.90%
6M Leistung:
-36.66%
1J Leistung:
-14.79%
1-Tages-Spanne:
$3.01
$3.23
1-Wochen-Bereich:
$2.81
$3.38
52-Wochen-Spanne:
$1.90
$6.08
Codexis Inc Stock (CDXS) Company Profile
Firmenname
Codexis Inc
Sektor
Branche
Telefon
650-421-8100
Adresse
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Vergleichen Sie CDXS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDXS
Codexis Inc
|
3.11 | 268.42M | 70.14M | -76.24M | -57.06M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-19 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-05-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-29 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-11-07 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-08-07 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-05-09 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-03-31 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2021-04-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-03-01 | Eingeleitet | Stifel | Buy |
| 2021-02-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-10 | Eingeleitet | The Benchmark Company | Buy |
| 2019-01-17 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-05-16 | Eingeleitet | Stephens | Overweight |
| 2017-10-13 | Bestätigt | H.C. Wainwright | Buy |
| 2017-05-31 | Eingeleitet | Jefferies | Buy |
| 2017-01-26 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-01-04 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2016-01-06 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Codexis Inc Aktie (CDXS) Neueste Nachrichten
Visual trend scoring systems applied to Codexis Inc.Daily Pick Forecast with Entry Zones - Newser
Is Codexis Inc. stock ready for a breakoutFundamental Analysis for Value Stock Selection - Newser
Visual analytics tools that track Codexis Inc. performancePredictive System for Long-Term Stock Forecast - Newser
Private Advisor Group LLC Has $922,000 Stock Holdings in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Is Codexis Inc. a growth stock or a value stockConsistently superior profits - jammulinksnews.com
Pattern recognition hints at Codexis Inc. upside Free AI Driven Stock Trend Forecast - Newser
How strong is Codexis Inc. company’s balance sheetMaximize portfolio growth with strategic plans - jammulinksnews.com
What are Codexis Inc. company’s key revenue driversGet exclusive access to premium stock research - jammulinksnews.com
Why Codexis Inc. stock attracts strong analyst attentionLow Volatility High Yield Stocks - metal.it
How does Codexis Inc. compare to its industry peersBuild a portfolio that withstands market volatility - jammulinksnews.com
What is the dividend policy of Codexis Inc. stockFastest-growing stock picks - jammulinksnews.com
How Codexis Inc. stock performs during market volatilityLong Term Secure Gain Stocks - Newser
Codexis Inc. Stock Support and Resistance Levels You Should KnowLong Term Secure Gain Stocks - Newser
What makes Codexis Inc. stock price move sharplySecure Your Capital Strategy - Newser
Codexis Confronts Trade Policy Challenges: Tariffs and Sanctions Threaten Operations - TipRanks
What analysts say about Codexis Inc. stockRapid growth opportunities - Autocar Professional
Is Codexis Inc. a good long term investmentFree Popular Stock Recommendations - PrintWeekIndia
What drives Codexis Inc. stock priceBreakthrough investment results - PrintWeekIndia
How Codexis Inc. stock compares to its top competitorsIs CNFRZ stock undervalued or overvalued nowSignificant capital appreciation - jammulinksnews.com
Codexis Inc. Stock Analysis and ForecastRobust investment performance - Autocar Professional
Major Shareholder Makes Bold Move with Codexis Stock Purchase - TipRanks
Enzymatic Solutions Leader Codexis Reveals Growth Strategy at Jefferies Healthcare Conference - Stock Titan
Finanzdaten der Codexis Inc-Aktie (CDXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.97%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):